Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

PLoS Pathogens

Topics

Biology

Immunology

Medicine

Infectious Diseases

Radiology, Nuclear Medicine And Imaging

Show all topics

DOI

10.1371/journal.ppat.1011569

License

CC-BY